Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrug ▼Date fromSubject
 2.3.2022Pfizer Europe MA EEIG (PFI-BE-3)27551ACCUZIDE 10 (tbl flm 100x10 mg/12,5 mg (blis. PVC/PVDC/Al))1.3.2022R
 22.1.2020Pfizer Europe MA EEIG (PFI-BE-3)27551ACCUZIDE 10 (tbl flm 100x10 mg/12,5 mg (blis. PVC/PVDC/Al))22.1.2020O
 22.1.2020Pfizer Europe MA EEIG (PFI-BE-3)27551ACCUZIDE 10 (tbl flm 100x10 mg/12,5 mg (blis. PVC/PVDC/Al))24.1.2020O
 2.3.2022Pfizer Europe MA EEIG (PFI-BE-3)27549ACCUZIDE 10 (tbl flm 30x10 mg/12,5 mg (blis. PVC/PVDC/Al))1.3.2022R
 30.9.2019Pfizer Europe MA EEIG (PFI-BE-3)27549ACCUZIDE 10 (tbl flm 30x10 mg/12,5 mg (blis. PVC/PVDC/Al))10.10.2019R
 11.3.2020Pfizer Europe MA EEIG (PFI-BE-3)27549ACCUZIDE 10 (tbl flm 30x10 mg/12,5 mg (blis. PVC/PVDC/Al))13.3.2020O
 24.3.2020Pfizer Europe MA EEIG (PFI-BE-3)64790ACCUZIDE 20 (tbl flm 100x20 mg/12,5 mg (blis. PVC/PVDC/Al))25.3.2020O
 2.3.2022Pfizer Europe MA EEIG (PFI-BE-3)64790ACCUZIDE 20 (tbl flm 100x20 mg/12,5 mg (blis. PVC/PVDC/Al))1.3.2022R
 2.3.2022Pfizer Europe MA EEIG (PFI-BE-3)64788ACCUZIDE 20 (tbl flm 30x20 mg/12,5 mg (blis. PVC/PVDC/Al))1.3.2022R
 6.4.2020Pfizer Europe MA EEIG (PFI-BE-3)64788ACCUZIDE 20 (tbl flm 30x20 mg/12,5 mg (blis. PVC/PVDC/Al))7.4.2020O
 24.3.2020Herbacos Recordati s.r.o. (HEO-1)88690ACIFEIN (tbl 10 (blis.PVC/Al))26.3.2020R
 30.4.2020Herbacos Recordati s.r.o. (HEO-1)88690ACIFEIN (tbl 10 (blis.PVC/Al))5.5.2020O
 21.5.2021Herbacos Recordati s.r.o. (HEO-1)88690ACIFEIN (tbl 10 (blis.PVC/Al))21.5.2021R
 2.6.2022Herbacos Recordati s.r.o. (HEO-1)5728DACIFEIN (tbl 20 (2x10) (blis.PVC/Al))2.6.2022Z
 2.12.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-4)90197Aclasta 5 mg infúzny roztok (sol inf 1x100 ml/5 mg (fľ.plast.))1.12.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To